Soy and the soy isoflavone genistein promote adipose tissue development in male mice on a low-fat diet

European Journal of Nutrition

Volumn 54, Issue 7, 2015, Pages 1095-1107

  Zanella, Isabella ^a,b   Marrazzo, Eleonora ^a   Biasiotto, Giorgio ^a,b   Penza, Marialetizia ^a   Romani, Annalisa ^c   Vignolini, Pamela ^c   Caimi, Luigi ^b   Di Lorenzo, Diego ^a  

^a Civic Hospital of Brescia   (Italy)

^b UNIVERSITY OF BRESCIA   (Italy)

^c UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Adipocyte differentiation; Adipose deposition; Estrogen receptors; Phytoestrogens

Indexed keywords

ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FIBROBLAST GROWTH FACTOR; GENISTEIN; HORMONE SENSITIVE LIPASE; LIPOPROTEIN LIPASE; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHOSPHOLIPASE A2; PHOSPHOLIPASE A2 GROUP VII; TRIACYLGLYCEROL LIPASE; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN RECEPTOR; TRANSCRIPTOME;

3T3 CELL LINE; ADIPOCYTE; ADIPOGENESIS; ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY FAT; CELL DIFFERENTIATION; CONTROLLED STUDY; DOWN REGULATION; DRUG BLOOD LEVEL; FAT MASS; GENE EXPRESSION PROFILING; GENETIC TRANSFECTION; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; IN VITRO STUDY; IN VIVO STUDY; INSULIN SENSITIVITY; INTRAABDOMINAL FAT; LIPID STORAGE; LOW FAT DIET; MALE; MOUSE; NONHUMAN; PROADIPOCYTE; SOYBEAN; TRANSCRIPTION INITIATION; TREATMENT DURATION; UPREGULATION; ANIMAL; BLOOD; C57BL MOUSE; CHEMISTRY; DRUG EFFECTS; GENETICS; GLUCOSE TOLERANCE TEST; METABOLISM;

3T3-L1 CELLS; ADIPOGENESIS; ADIPOSE TISSUE; ANIMALS; CELL DIFFERENTIATION; DIET, FAT-RESTRICTED; DOWN-REGULATION; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GENISTEIN; GLUCOSE TOLERANCE TEST; MALE; MICE; MICE, INBRED C57BL; PPAR GAMMA; SOYBEANS; TRANSCRIPTOME;

EID: 84942366210     PISSN: 14366207     EISSN: 14366215     Source Type: Journal    
DOI: 10.1007/s00394-014-0786-9     Document Type: Article

References (50)

1. Brown LM, Clegg DJ (2010) Central effects of estradiol in the regulation of food intake, body weight, and adiposity. J Steroid Biochem Mol Biol 122:65–73
2. Gormsen LC, Høst C, Hjerrild BE, Pedersen SB, Nielsen S, Christiansen JS, Gravholt CH (2012) Estradiol acutely inhibits whole body lipid oxidation and attenuates lipolysis in subcutaneous adipose tissue: a randomized, placebo-controlled study in postmenopausal women. Eur J Endocrinol 167:543–551
3. Faulds MH, Zhao C, Dahlman-Wright K, Gustafsson J (2012) The diversity of sex steroid action: regulation of metabolism by estrogen signaling. J Endocrinol 212:3–12
4. Manrique C, Lastra G, Habibi J, Mugerfeld I, Garro M, Sowers JR (2012) Loss of estrogen receptor α signaling leads to insulin resistance and obesity in young and adult female mice. Cardiorenal Med 2:200–210
5. Davis KE, Neinast MD, Sun K, Skiles WM, Bills JD, Zehr JD, Zeve D, Hahner LD et al (2013) The sexually dimorphic role of adipose and adipocyte estrogen receptors in modulating adipose tissue expansion, inflammation, and fibrosis. Mol Metab 2:227–242
6. Huang P, Chandra V, Rastinejad F (2010) Structural overview of the nuclear receptor superfamily: insights into physiologycand therapeutics. Annu Rev Physiol 72:247–272
7. Penza M, Montani C, Romani A, Vignolini P, Pampaloni B, Tanini A, Brandi ML, Alonso-Magdalena P, Nadal A et al (2006) Genistein affects adipose tissue deposition in a dose-dependent and gender-specific manner. Endocrinology 147:5740–5751
8. Yepuru M, Eswaraka J, Kearbey JD, Barrett CM, Raghow S, Veverka KA, Miller DD, Dalton JT, Narayanan R (2010) Estrogen receptor-beta-selective ligands alleviate high-fat diet- and ovariectomy-induced obesity in mice. J Biol Chem 285:31292–31303
9. Barros RP, Gustafsson J (2011) Estrogen receptors and the metabolic network. Cell Metab 14:289–299
10. Hao CJ, Cheng XJ, Xia HF, Ma X (2012) The endocrine disruptor diethylstilbestrol induces adipocyte differentiation and promotes obesity in mice. Toxicol Appl Pharmacol 263:102–110
11. Foryst-Ludwig A, Kintscher U (2010) Metabolic impact of estrogen signalling through ERalpha and ERbeta. J Steroid Biochem Mol Biol 122:74–81
12. Seidlova-Wuttke D, Nguyen BT, Wuttke W (2012) Long-term effects of ovariectomy on osteoporosis and obesity in estrogen-receptor-β-deleted mice. Comp Med 62:8–13
13. Foryst-Ludwig A, Clemenz M, Hohmann S, Hartge M, Sprang C, Frost N, Krikov M, Bhanot S, Barros R et al (2008) Metabolic actions of estrogen receptor beta (ERbeta) are mediated by a negative cross-talk with PPARgamma. PLoS Genet 4:e1000108
14. Adlercreutz H (2007) Lignans and human health. Crit Rev Clin Lab Sci 44:483–525
15. Ørgaard A, Jensen L (2008) The effects of soy isoflavones on obesity. Exp Biol Med (Maywood) 233:1066–1080
16. Cederroth CR, Nef S (2009) Soy, phytoestrogens and metabolism: a review. Mol Cell Endocrinol 304:30–42
17. Smoliga JM, Baur JA, Hausenblas HA (2011) Resveratrol and health: a comprehensive review of human clinical trials. Mol Nutr Food Res 55:1129–1141
18. Kuiper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT, van der Burg B, Gustafsson JA (1998) Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 139:4252–4263
19. Merritt JC (2004) Metabolic syndrome: soybean foods and serum lipids. J Natl Med Assoc 96:1032–1041
20. Nhan S, Anderson KE, Nagamani M, Grady JJ, Lu LJ (2005) Effect of a soymilk supplement containing isoflavones on urinary F2 isoprostane levels in premenopausal women. Nutr Cancer 53:73–81
21. Wu SH, Shu XO, Chow WH, Xiang YB, Zhang X, Li HL, Cai Q, Ji BT, Cai H et al (2012) Soy food intake and circulating levels of inflammatory markers in Chinese women. J Acad Nutr Diet 112:996–1004
22. Romagnolo DF, Selmin OI (2012) Flavonoids and cancer prevention: a review of the evidence. J Nutr Gerontol Geriatr 31:206–238
23. Jefferson WN (2010) Adult ovarian function can be affected by high levels of soy. J Nutr 140:2322S–2325S
24. Ollberding NJ, Lim U, Wilkens LR, Setiawan VW, Shvetsov YB, Henderson BE, Kolonel LN, Goodman MT (2012) Legume, soy, tofu, and isoflavone intake and endometrial cancer risk in postmenopausal women in the multiethnic cohort study. J Natl Cancer Inst 104:67–76
25. Nguyen BT, Kararigas G, Jarry H (2013) Dose-dependent effects of a genistein-enriched diet in the heart of ovariectomized mice. Genes Nutr 8:383–390
26. Jeong S, Yoon M (2011) 17β-Estradiol inhibition of PPARγ-induced adipogenesis and adipocyte-specific gene expression. Acta Pharmacol Sin 32:230–238
27. Keller H, Givel F, Perroud M, Wahli W (1995) Signaling cross-talk between peroxisome proliferator-activated receptor/retinoid X receptor and estrogen receptor through estrogen response elements. Mol Endocrinol 9:794–804
28. Bonofiglio D, Gabriele S, Aquila S, Catalano S, Gentile M, Middea E, Giordano F, Andò S (2005) Estrogen receptor alpha binds to peroxisome proliferator-activated receptor response element and negatively interferes with peroxisome proliferator-activated receptor gamma signaling in breast cancer cells. Clin Cancer Res 11:6139–6147
29. Clifton PM (2011) Protein and coronary heart disease: the role of different protein sources. Curr Atheroscler Rep 13:493–498
30. Setchell KD, Brown NM, Desai PB, Zimmer-Nechimias L, Wolfe B, Jakate AS, Creutzinger V, Heubi JE (2003) Bioavailability, disposition, and dose-response effects of soy isoflavones when consumed by healthy women at physiologically typical dietary intakes. J Nutr 133:1027–1035
31. Gardner CD, Chatterjee LM, Franke AA (2009) Effects of isoflavone supplements versus soy foods on blood concentrations of genistein and daidzein in adults. J Nutr Biochem 20:227–234
32. Manach C, Morand C, Crespy V, Demigné C, Texier O, Régérat F, Rémésy C (1998) Quercetin is recovered in human plasma as conjugated derivatives which retain antioxidant properties. FEBS Lett 426:331–336
33. 2002 Statistical algorithms description document. Affymetrix manual
34. Taylor J, Tibshirani R, Efron B (2005) The “miss rate” for the analysis of gene expression data. Biostatistics 6:111–117
35. Smith GK (2005) Limma: linear models for microarray data. In: Gentleman R, Carey V, Dudoit S, Irizarry R, Huber W (eds) Bioinformatics and computational biology solutions using R and bioconductor. Springer, New York, pp 397–420
36. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, Ellis B, Gautier L, Ge Y, Gentry J, Hornik K, Hothorn T, Huber W, Iacus S, Irizarry R, Leisch F, Li C, Maechler M, Rossini AJ, Sawitzki G, Smith C, Smyth G, Tierney L, Yang JY, Zhang J (2004) Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 5:R80
37. Penza M, Jeremic M, Marrazzo E, Maggi A, Ciana P, Rando G, Grigolato PG, Di Lorenzo D (2011) The environmental chemical tributyltin chloride (TBT) shows both estrogenic and adipogenic activities in mice which might depend on the exposure dose. Toxicol Appl Pharmacol 255:65–75
38. Cy C, Norris JD, Grøn H, Paige LA, Hamilton PT, Kenan DJ, Fowlkes D, McDonnell DP (1999) Dissection of the LXXLL nuclear receptor-coactivator interaction motif using combinatorial peptide libraries: discovery of peptide antagonists of estrogen receptors alpha and beta. Mol Cell Biol 19:8226–8239
39. Graves RA, Tontonoz P, Spiegelman BM (1992) Analysis of a tissue-specific enhancer: ARF6 regulates adipogenic gene expression. Mol Cell Biol 12:1202–1208
40. Dang ZC, Audinot V, Papapoulos SE, Boutin JA, Löwik CW (2003) Peroxisome proliferator-activated receptor gamma (PPARgamma) as a molecular target for the soy phytoestrogen genistein. J Biol Chem 278:962–967
41. Lundholm L, Zang H, Hirschberg AL, Gustafsson JA, Arner P, Dahlman-Wright K (2008) Key lipogenic gene expression can be decreased by estrogen in human adipose tissue. Fertil Steril 90:44–48
42. Cristancho AG, Lazar MA (2011) Forming functional fat: a growing understanding of adipocyte differentiation. Nat Rev Mol Cell Biol 12:722–734
43. Kershaw EE, Schupp M, Guan HP, Gardner NP, Lazar MA, Flier JS (2007) PPARgamma regulates adipose triglyceride lipase in adipocytes in vitro and in vivo. Am J Physiol Endocrinol Metab 293:E1736–E1745
44. De Naeyer H, Ouwens DM, Van Nieuwenhove Y, Pattyn P, ‘t Hart LM, Kaufman JM, Sell H, Eckel J, Cuvelier C et al (2011) Combined gene and protein expression of hormone-sensitive lipase and adipose triglyceride lipase, mitochondrial content, and adipocyte size in subcutaneous and visceral adipose tissue of morbidly obese men. Obes Facts 4:407–416
45. Matthies A, Loh G, Blaut M, Braune A (2012) Daidzein and genistein are converted to equol and 5-hydroxy-equol by human intestinal Slackia isoflavoniconvertens in gnotobiotic rats. J Nutr 142:40–46
46. Coughlan N, Thillainadesan G, Andrews J, Isovic M, Torchia J (2013) β-estradiol-dependent activation of the Jak/Stat pathway requires p/CIP and CARM1. Biochim Biophys Acta 1833:1463–1475
47. Yadav N, Cheng D, Richard S, Morel M, Iyer VR, Aldaz CM, Bedford MT (2008) CARM1 promotes adipocyte differentiation by coactivating PPARgamma. EMBO Rep 9:193–198
48. Wang X, Kilgore MW (2002) Signal cross-talk between estrogen receptor alpha and beta and the peroxisome proliferator-activated receptor gamma1 in MDA-MB-231 and MCF-7 breast cancer cells. Mol Cell Endocrinol 194:123–133
49. Liao QC, Li YL, Qin YF, Quarles LD, Xu KK, Li R, Zhou HH, Xiao ZS (2008) Inhibition of adipocyte differentiation by phytoestrogen genistein through a potential downregulation of extracellular signal-regulated kinases 1/2 activity. J Cell Biochem 104:1853–1864
50. Liao FH, Shieh MJ, Yang SC, Lin SH, Chien YW (2007) Effectiveness of a soy-based compared with a traditional low-calorie diet on weight loss and lipid levels in overweight adults. Nutrition 23:551–556